● TIER 3 — Information onlyGRADE B (one placebo-controlled RCT, Russian; Cochrane included it)Nootropic / neuro peptides
Cortexin (Кортексин)
Origin: Russia (Geropharm). Citations verified: yes. 3 human study record(s) in the FitClinicMD studies database.
GOALS · Cognition
FDA status
Not an FDA-approved product
Compounding (503A/503B)
Status varies — see notes
DEA
Not listed as controlled
WADA (sport)
Not specified
Mechanism
Polypeptide fraction from cerebral cortex of livestock; claimed neuroprotective.
Human evidence · 3
Cochrane 2023 update (Cerebrolysin and Cortexin for acute ischaemic stroke).
2023systematic review
2014 PubMed report of the Cortexin low-dose stroke trial.
Stakhovskaya et al., Bulletin of the Russian Military Medical Academy (RCT, n=272).
RCTn=272
Reference only. This page summarizes publicly available regulatory and research information about Cortexin (Кортексин). It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.